TABLE 2

Sites of Recurrent or Metastatic PCa Detected on PSMA-Targeted 18F-DCFPyL PET/CT

Anatomic locationAll patients (n = 31)PSA 0.2–1.0 ng/mL (n = 22)PSA > 1.0 ng/mL (n = 9)
Prostate bed8 (25.8)6 (27.2)2 (22.2)
Pelvic lymph node14 (45.1)6 (27.2)8 (88.9)
Nonpelvic lymph node2 (6.5)0 (0.0)2 (22.2)
Bone2 (6.5)1 (4.5)1 (11.1)
Viscera0 (0.0)0 (0.0)0 (0.0)
Any site21 (67.7)13 (59.1)8 (88.9)
>1 site5 (16.1)0 (0.0)5 (55.6)
  • Data are expressed as numbers followed by percentages in parentheses.